Selected Grants
Advanced body composition imaging to improve outcomes in lung transplantation
ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2025 - 2030Lung Transplant Clinical Trial Network (LT-CTN)
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 20288134 PROMISE-Lung Study _ Site Agreement for Duke-as-a-site (#101, Dr. Snyder)
Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2023 - 2027Clinical and Mechanistic Factors Impacting Transplant Outcomes (U01)
ResearchPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2027Identifying acute lung allograft dysfunction in lung transplant recipients and evaluating its relationship in developing chronic lung allograft dysfunction
ResearchCo Investigator · Awarded by Cystic Fibrosis Foundation · 2025 - 2027Understanding the Role of Cytomegalovirus in the Pathogenesis and Prevention of CLAD
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2025 - 2027Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2026Cystic Fibrosis Lung Transplant Consortium
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2020 - 2026Program for Adult Care Excellence in Cystic Fibrosis 2024
ResearchMentor · Awarded by Cystic Fibrosis Foundation · 2023 - 2026Reducing Polypharmacy and Fall Risk for Multi-Morbid Adults with Chronic Obstructive Pulmonary Disease
ResearchCo-Mentor · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2026A Phase III, Multicentre, Randomised, Double-blind, Chronic Dosing, Parallel Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of MEDI3506 in Participants with Symptomatic Chronic Obstructive Pulmonary Disease
Clinical TrialPrincipal Investigator · Awarded by MedImmune Limited · 2021 - 2026Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab
Clinical TrialCo Investigator · Awarded by Massachusetts General Hospital · 2021 - 2026Creation of a Data Asset to Identify Barriers in Access to Lung Transplant
ResearchCollaborating Investigator · Awarded by Cystic Fibrosis Foundation · 2025 - 2026Long Term Follow up of the Lung Transplant Outcomes Group Cohort
ResearchCo Investigator · Awarded by University of Pennsylvania · 2019 - 2026Improving Lung Transplant Outcomes with Coping Skills and Physical Activity
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2026Duke UNC Cystic Fibrosis Tissue Procurement Partnership 2025-2026
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2025 - 2026Gliptin use and impact on chronic lung allograft rejection
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2023 - 2025Duke - UNC Cystic Fibrosis Tissue Procurement Partnership
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2018 - 2025Evaluating PFT trends for the development of Baseline Lung Allograft Dysfunction after lung transplantation
ResearchCollaborator · Awarded by International Society for Heart & Lung Transplantation · 2024 - 2024UWash CFF - Isolation of Pseudomonas aeruginosa from respiratory specimens after lung transplantation and the development of chronic lung allograft dysfunction
ResearchPrincipal Investigator · Awarded by Washington University in St. Louis · 2023 - 2024Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024CTOT Long-Term Extension Study
ResearchCo Investigator · Awarded by Cystic Fibrosis Foundation · 2019 - 2024CF LTT RDN Expansion Mini Grant Funding
ResearchPrincipal Investigator · Awarded by University of New Hampshire · 2021 - 2023Defining optimal tacrolimus dosing and concentrations in the early post-lung transplant period based on short- and long-term clinical impacts
ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2022 - 2023Clinical and Molecular Epidemiology of Acute Kidney Injury After Lung Transplant
ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2017 - 2023AZ Pulse Ox Study_LOI
ResearchPrincipal Investigator · Awarded by AstraZeneca LP · 2021 - 2023Cystic Fibrosis Lung Transplant and Transition Regional Dissemination Network - Mini-Grant for Continued Quality Improvement
ResearchPrincipal Investigator · Awarded by University of New Hampshire · 2021 - 2021DeNovo DSA to predict treatment response
ResearchCo Investigator · Awarded by Icahn School of Medicine at Mount Sinai · 2020 - 2021The Lung Transplant Clinical Trials Network (LT-CTN)
ResearchCo Investigator · Awarded by National Institutes of Health · 2014 - 2021Impact of patient specific factors on CF lung transplant outcomes
ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2019 - 2020Lung Transplant Plasmapheresis (PLEX)/Belatacept/Carfilzomib Protocol for Treatment of Antibody Mediated Rejection (AMR) and Desensitization
Clinical TrialCo-Principal Investigator · Awarded by Bristol-Myers Squibb Company · 2019 - 2020Cystic Fibrosis Lung Transplant Transition - Regional Dissemination Network
ResearchPrincipal Investigator · Awarded by Dartmouth College · 2019 - 2020Cystic Fibrosis Lung Transplant Consortium
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation Therapeutics, Inc. · 2017 - 2019The interface of B and T cells in Transplant
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation Therapeutics, Inc. · 2016 - 2019CF Lung Transplant Transition LLC Phase 2 Program Extension Post NACFC October 2018 through May 30, 2019
ResearchPrincipal Investigator · Awarded by Dartmouth College · 2018 - 2019Clinical features of lung transplant recipients with prolonged survival (>15 years) from the ISHLT registry
ResearchMentor · Awarded by International Society for Heart & Lung Transplantation · 2018 - 2019Clinical Risk Factors for Primary Graft Dysfunction
ResearchCo Investigator · Awarded by University of Pennsylvania · 2015 - 2018Predictors and Outcomes of Post-transplant lymphoproliferative disorder in lung transplant recipients
ResearchMentor · Awarded by International Society for Heart & Lung Transplantation · 2017 - 2018GS-US-218-1797
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2015 - 2017Hyaluronan in Acute Rejection and Chronic Lung Allograft Dysfunction after Human Lung Transplantation
ResearchCo Investigator · Awarded by Mount Sinai School of Medicine · 2016 - 2017eConnectivity COPD Study LOI
Clinical TrialPrincipal Investigator · Awarded by Teva Pharmaceutical Industries, Ltd · 2017 - 2017Novel Cellular Immune Profiles to Predict Lung Disease Outcomes
ResearchCo Investigator · Awarded by National Institutes of Health · 2011 - 2013External Relationships
- AstraZeneca
- Transmedics
- Zambon SpA
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.